Literature DB >> 16182380

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.

Sergio Monteiro de Almeida1, Scott Letendre, Joshua Zimmerman, Deborah Lazzaretto, Allen McCutchan, Ronald Ellis.   

Abstract

BACKGROUND: Increased expression of monocyte chemoattractant protein type 1 (MCP-1) is associated with HIV CNS disease. This study evaluated the temporal relationships between MCP-1 expression and HIV replication in the CNS.
METHODS: MCP-1 and HIV viral load (VL) were measured in serially obtained samples of plasma and cerebrospinal fluid (CSF) in subjects either interrupting (TI) or starting (TS) antiretroviral therapy.
RESULTS: Following TI, plasma VL rebounded first, followed by increases in CSF MCP-1, which immediately preceded or coincided with a rebound of CSF VL.
CONCLUSION: The close temporal relationship of the increase of MCP-1 and CSF VL suggests that they are co-regulated, or that one is a stimulus for the other.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182380     DOI: 10.1016/j.jneuroim.2005.07.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.

Authors:  Charles L Raison; Andrey S Borisov; Matthias Majer; Daniel F Drake; Giuseppe Pagnoni; Bobbi J Woolwine; Gerald J Vogt; Breanne Massung; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2008-09-18       Impact factor: 13.382

2.  Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.

Authors:  Tricia H Burdo; Allison Weiffenbach; Steven P Woods; Scott Letendre; Ronald J Ellis; Kenneth C Williams
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

3.  Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.

Authors:  Albert M Anderson; Jaroslaw Harezlak; Ajay Bharti; Deming Mi; Michael J Taylor; Eric S Daar; Giovanni Schifitto; Jianhui Zhong; Jeffry R Alger; Mark S Brown; Elyse J Singer; Thomas B Campbell; Deborah D McMahon; Steven Buchthal; Ronald Cohen; Constantin Yiannoutsos; Scott L Letendre; Bradford A Navia
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

4.  Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.

Authors:  Alex K Bryant; David J Moore; Tricia H Burdo; Jessica R Lakritz; Ben Gouaux; Virawudh Soontornniyomkij; Cristian L Achim; Eliezer Masliah; Igor Grant; Andrew J Levine; Ronald J Ellis
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

5.  Plasma cytokine levels are related to brain volumes in HIV-infected individuals.

Authors:  Assawin Gongvatana; Stephen Correia; Shira Dunsiger; Lynne Gauthier; Kathryn N Devlin; Skye Ross; Bradford Navia; Karen T Tashima; Suzanne DeLaMonte; Ronald A Cohen
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-02       Impact factor: 4.147

6.  Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders.

Authors:  Melissa A Agsalda-Garcia; Pasiri Sithinamsuwan; Victor G Valcour; Thep Chalermchai; Somporn Tipsuk; Jason Kuroda; Christie Nakamura; Jintanat Ananworanich; Guangxiang Zhang; Alexandra Schuetz; Bonnie M Slike; Bruce Shiramizu
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

7.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

Review 8.  Antiretroviral therapy and central nervous system HIV type 1 infection.

Authors:  Richard W Price; Serena Spudich
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

9.  Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

Authors:  Gabriele Arendt; Thorsten Nolting; Christian Frisch; Ingo-Wilhelm Husstedt; Nora Gregor; Eleni Koutsilieri; Mattias Maschke; Alexander Angerer; Mark Obermann; Eva Neuen-Jacob; Ortwin Adams; Sabine Loeffert; Peter Riederer; Volker ter Meulen; Sieghart Sopper
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

10.  Coordinated regulation of SIV replication and immune responses in the CNS.

Authors:  Kenneth W Witwer; Lucio Gama; Ming Li; Christopher M Bartizal; Suzanne E Queen; John J Varrone; Angela K Brice; David R Graham; Patrick M Tarwater; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.